{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:21:32Z","timestamp":1785842492906,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1245\/s10434-017-5963-7","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T13:04:51Z","timestamp":1501592691000},"page":"3060-3066","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Expanded Gene Panel Use for Women With Breast Cancer: Identification and Intervention Beyond Breast Cancer Risk"],"prefix":"10.1245","volume":"24","author":[{"given":"Erin","family":"O\u2019Leary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Iacoboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Holle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott T.","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Esplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"5963_CR1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78\u201385.","journal-title":"N Engl J Med."},{"key":"5963_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng853","volume":"31","author":"PD Pharoah","year":"2002","unstructured":"Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet. 2002;31:33\u20136.","journal-title":"Nat Genet."},{"key":"5963_CR3","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Genetic\/familial high-risk assessment: breast and ovarian. Version 2.2017. https:\/\/www.nccn.org\/ . Accessed 31 March 2017."},{"key":"5963_CR4","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Genetic\/familial high-risk assessment: colorectal. Version 2.2016. https:\/\/www.nccn.org\/ . Accessed 31 March 2017."},{"key":"5963_CR5","unstructured":"The American Society of Breast Surgeons Consensus Guideline on Hereditary Genetic Testing for Patients With and Without Breast Cancer (revised March 14, 2017). https:\/\/www.breastsurgeons.org\/new_layout\/about\/statements\/PDF_Statements\/BRCA_Testing.pdf . Accessed 1 April 2017."},{"key":"5963_CR6","unstructured":"Society of Gynecologic Oncology Clinical Practice Statement: Genetic Testing for Ovarian Cancer. Retrieved 31 March 2017 at https:\/\/www.sgo.org\/clinical-practice\/guidelines\/genetic-testing-for-ovarian-cancer\/ ."},{"key":"5963_CR7","doi-asserted-by":"crossref","unstructured":"American College of Obstetrics and Gynecologists, et al. ACOG Practice Bulletin no. 103: Hereditary breast and ovarian cancer syndrome. Obstet Gynecol. 2009;113:957\u201366.","DOI":"10.1097\/AOG.0b013e3181a106d4"},{"key":"5963_CR8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nrclinonc.2012.123","volume":"9","author":"KN Maxwell","year":"2012","unstructured":"Maxwell KN, Domchek SM. Cancer treatment according to BRCA1 and BRCA2 mutations. Nat Rev Clin Oncol. 2012;9:520\u20138.","journal-title":"Nat Rev Clin Oncol."},{"key":"5963_CR9","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1200\/JCO.2009.22.7967","volume":"27","author":"J Tinat","year":"2009","unstructured":"Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, Bouvignies E, et al. 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol. 2009;27:e108\u20139.","journal-title":"J Clin Oncol."},{"key":"5963_CR10","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jnci\/djt277","volume":"105","author":"R Pilarski","year":"2013","unstructured":"Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2013;105:1607\u201316.","journal-title":"J Natl Cancer Inst."},{"key":"5963_CR11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg3463","volume":"14","author":"HL Rehm","year":"2013","unstructured":"Rehm HL. Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet. 2013;14:295\u2013300.","journal-title":"Nat Rev Genet."},{"key":"5963_CR12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajhg.2009.06.022","volume":"85","author":"T Tucker","year":"2009","unstructured":"Tucker T, Marra M, Friedman JM. Massively parallel sequencing: the next big thing in genetic medicine. Am J Hum Genet. 2009;85:142\u201354.","journal-title":"Am J Hum Genet."},{"key":"5963_CR13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamainternmed.2013.12048","volume":"174","author":"KA Johansen Taber","year":"2014","unstructured":"Johansen Taber KA, Dickinson BD, Wilson M. The promise and challenges of next-generation genome sequencing for clinical care. JAMA Intern Med. 2014;174:275\u201380.","journal-title":"JAMA Intern Med."},{"key":"5963_CR14","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","volume":"32","author":"AW Kurian","year":"2014","unstructured":"Kurian AW, Hare EE, Mills MA, Kingham KE, McPherson L, Whittemore AS, et al. Clinical evaluation of a multiple gene sequencing panel for hereditary cancer risk assessment. J Clin Oncol. 2014;32:2001\u20139.","journal-title":"J Clin Oncol."},{"key":"5963_CR15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015;121:25\u201333.","journal-title":"Cancer."},{"key":"5963_CR16","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/gim.2014.40","volume":"16","author":"H LaDuca","year":"2014","unstructured":"LaDuca H, Stuenkel AJ, Dolinsky JS, Keiles S, Tandy S, Pesaran T, et al. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2000 patients. Genet Med. 2014;16:830\u20137.","journal-title":"Genet Med."},{"key":"5963_CR17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gim.2014.176","volume":"17","author":"KN Maxwell","year":"2015","unstructured":"Maxwell KN, Wubbenhorst B, D\u2019Andrea K, Garman B, Long JM, Powers J, et al. Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1\/2-negative patients with early-onset breast cancer. Genet Med. 2015;17:630\u20138.","journal-title":"Genet Med."},{"key":"5963_CR18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jmoldx.2015.04.009","volume":"17","author":"SE Lincoln","year":"2015","unstructured":"Lincoln SE, Kobayashi Y, Anderson MJ, Yang S, Desmond AJ, Mills MA, et al. A systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients. J Mol Diagn. 2015;17:533\u201344.","journal-title":"J Mol Diagn."},{"key":"5963_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.37","author":"K Nykamp","year":"2017","unstructured":"Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho, Y, et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med. DOI: 10.1038\/gim.2017.37 .","journal-title":"Genet Med."},{"issue":"9","key":"5963_CR20","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.6004\/jnccn.2014.0128","volume":"12","author":"MJ Hall","year":"2014","unstructured":"Hall MJ, Forman AD, Pilarski R, Wiesner G, Giri VN. Gene panel testing for inherited cancer risk. J Natl Compr Cancer Netw. 2014;12(9):1339\u201346.","journal-title":"J Natl Compr Cancer Netw."},{"key":"5963_CR21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/gim.2013.160","volume":"16","author":"CB Mauer","year":"2014","unstructured":"Mauer CB, Pirzadeh-Miller SM, Robinson LD, Euhus DM. The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience. Genet Med. 2014;16:407\u201312.","journal-title":"Genet Med."},{"key":"5963_CR22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10897-014-9714-7","volume":"23","author":"H Fecteau","year":"2014","unstructured":"Fecteau H, Vogel KJ, Hanson K, Morrill-Cornelius S. The evolution of cancer risk assessment in the era of next generation sequencing. J Genet Couns. 2014;23:633\u20139.","journal-title":"J Genet Couns."},{"key":"5963_CR23","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, et al. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med. 2015;372:2243\u201357.","journal-title":"N Engl J Med."},{"key":"5963_CR24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1590\/1806-9282.61.03.282","volume":"61","author":"ER Thompson","year":"2015","unstructured":"Thompson ER, Rowley SM, Li N, McInerny S, Devereux L, Wong-Brown MW, et al. Panel testing for familial breast cancer: calibrating the tension between research and clinical care. Rev Assoc Med Bras. 2015:61:282\u20139.","journal-title":"Rev Assoc Med Bras."},{"key":"5963_CR25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/gtmb.2015.0061","volume":"19","author":"KR Blazer","year":"2015","unstructured":"Blazer KR, Nehoray B, Solomon I, Niell-Swiller M, Culver JO, Uman GC, Weitzel JN. Next-generation testing for cancer risk: perceptions, experiences, and needs among early adopters in community healthcare settings. Genet Test Mol Biomarkers. 2015;19:657\u201365.","journal-title":"Genet Test Mol Biomarkers."},{"key":"5963_CR26","first-page":"208","volume":"5","author":"TP Slavin","year":"2015","unstructured":"Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN. Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management. Front Oncol. 2015;5:208.","journal-title":"Front Oncol."},{"key":"5963_CR27","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/000313481508101006","volume":"81","author":"DR Howarth","year":"2015","unstructured":"Howarth DR, Lum SS, Esquivel P, Garberoglio CA, Senthil M, Solomon NL. Initial results of multigene panel testing for hereditary breast and ovarian cancer and Lynch syndrome. Am Surg. 2015;81:941\u20134.","journal-title":"Am Surg."},{"key":"5963_CR28","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","volume":"1","author":"A Desmond","year":"2015","unstructured":"Desmond A, Kurian AW, Gabree M, Mills MA, Anderson MJ, Kobayashi Y, et al. Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncol. 2015;1:943\u201351.","journal-title":"JAMA Oncol."},{"key":"5963_CR29","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","volume":"22","author":"L Cast\u00e9ra","year":"2014","unstructured":"Cast\u00e9ra L, Krieger S, Rousselin A, Legros A, Baumann JJ, Bruet O, et al. Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet. 2014;22:1305\u201313.","journal-title":"Eur J Hum Genet."},{"key":"5963_CR30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.2015.63.7454","volume":"34","author":"ER Thompson","year":"2016","unstructured":"Thompson ER, Rowley SM, Li N, McInerny S, Devereux L, Wong-Brown MW, et al. Panel testing for familial breast cancer: calibrating the tension between research and clinical care. J Clin Oncol. 2016;34:1455\u20139.","journal-title":"J Clin Oncol."},{"key":"5963_CR31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ajhg.2016.02.024","volume":"98","author":"KN Maxwell","year":"2016","unstructured":"Maxwell KN, Hart SN, Vijai J, Schrader KA, Slavin TP, Thomas T, et al. Evaluation of ACMG-guideline-based variant classification of cancer susceptibility and non\u2013cancer-associated genes in families affected by breast cancer. Am J Hum Genet. 2016;98:801\u201317.","journal-title":"Am J Hum Genet."},{"key":"5963_CR32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol. 2015;33:304\u201311.","journal-title":"J Clin Oncol."},{"key":"5963_CR33","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1053\/j.gastro.2008.12.050","volume":"136","author":"SP Cleary","year":"2009","unstructured":"Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009;136:1251\u201360.","journal-title":"Gastroenterology."},{"key":"5963_CR34","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1093\/hmg\/11.23.2961","volume":"11","author":"S Jones","year":"2002","unstructured":"Jones S, Emmerson P, Maynard J, Best JM, Jordan S, Williams GT, et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C\u2013>T:A mutations. Hum Mol Genet. 2002;11:2961\u20137.","journal-title":"Hum Mol Genet."},{"key":"5963_CR35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/ng828","volume":"30","author":"N Al-Tassan","year":"2002","unstructured":"Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, et al. Inherited variants of MYH associated with somatic G:C\u2013>T:A mutations in colorectal tumors. Nat Genet. 2002;30:227\u201332.","journal-title":"Nat Genet."},{"key":"5963_CR36","doi-asserted-by":"crossref","first-page":"294575","DOI":"10.1155\/2014\/294575","volume":"2014","author":"V Hale","year":"2014","unstructured":"Hale V, Weischer M, Park JY. CHEK2 (\u2217) 1100delC mutation and risk of prostate cancer. Prostate Cancer. 2014;2014:294575.","journal-title":"Prostate Cancer."},{"key":"5963_CR37","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1200\/JCO.2010.34.0778","volume":"29","author":"C Cybulski","year":"2011","unstructured":"Cybulski C, Woko\u0142orczyk D, Jakubowska A, Huzarski T, Byrski T, Gronwald J, et al. Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol. 2011;29:3747\u201352.","journal-title":"J Clin Oncol."},{"key":"5963_CR38","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.ejca.2011.03.025","volume":"47","author":"HP Xiang","year":"2011","unstructured":"Xiang HP, Geng XP, Ge WW, Li H. Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility. Eur J Cancer. 2011;47:2546\u201351.","journal-title":"Eur J Cancer."},{"key":"5963_CR39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-008-0162-7","volume":"116","author":"M Wasielewski","year":"2009","unstructured":"Wasielewski M, den Bakker MA, van den Ouweland A, Meijer-van Gelder ME, Portengen H, Klijn JG, et al. CHEK2 1100delC and male breast cancer in the Netherlands. Breast Cancer Res Treat. 2009;116:397\u2013400.","journal-title":"Breast Cancer Res Treat."},{"key":"5963_CR40","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","volume":"75","author":"C Cybulski","year":"2004","unstructured":"Cybulski C, G\u00f3rski B, Huzarski T, Masoj\u0107 B, Mierzejewski M, Debniak T, et al. CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet. 2004;75:1131\u20135.","journal-title":"Am J Hum Genet."},{"key":"5963_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2010.01402.x","volume":"78","author":"SA Narod","year":"2010","unstructured":"Narod SA. Testing for CHEK2 in the cancer genetics clinic: ready for prime time? Clin Genet. 2010;78:1\u20137.","journal-title":"Clin Genet."},{"key":"5963_CR42","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1188\/14.ONF.692-694","volume":"41","author":"SM Mahon","year":"2014","unstructured":"Mahon SM. Breast cancer risk associated with CHEK2 mutations. Oncol Nurs Forum. 2014;41:692\u20134.","journal-title":"Oncol Nurs Forum."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-017-5963-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:07:22Z","timestamp":1602634042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-017-5963-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["5963"],"URL":"https:\/\/doi.org\/10.1245\/s10434-017-5963-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}